# David Ebersman

> David A. Ebersman is the co-founder and board chairman of Lyra Health. He led the company as founding CEO from 2015 until January 2025, after serving as CFO of Facebook and Genentech. His career spans investment research, product development, operations, finance and company founding.

- **Role:** Co-founder and Board Chairman at Lyra Health
- **Organizations:** Lyra Health, Facebook, Genentech, Oppenheimer & Co., Brown University, SurveyMonkey / Momentive, Castlight Health, Ironwood Pharmaceuticals
- **From:** New York, United States
- **Nationality:** American
- **Education:** A.B. in Economics and International Relations, Brown University, Trinity School, New York
- **Known for:** Held senior leadership responsibilities across product development, operations and finance at Genentech., Led Genentech’s finance organisation during a period in which revenue tripled, according to Facebook’s 2009 hiring announcement., Helped lead Facebook through its May 2012 IPO.

## Career timeline

- **1991** — Graduated from Brown University and began working as a research analyst at Oppenheimer & Co.
- **1994** — Joined Genentech as a business development analyst; later held product development and product operations roles.
- **2000** — Selected for a Henry Crown Fellowship.
- **2005-03** — Became Genentech CFO.
- **2006-01** — Promoted to executive vice president at Genentech.
- **2009-09** — Joined Facebook as CFO.
- **2012-05** — Served as CFO during Facebook’s initial public offering.
- **2014-06** — Handed Facebook’s CFO role to David Wehner; remained with the company through September for the transition.
- **2014-10** — Brown University identified him as an entrepreneur in residence.
- **2015** — Co-founded Lyra Health with Dena Bravata and became founding CEO.
- **2025-01** — Became Lyra Health board chairman on January 13, as Jennifer Schulz became CEO.

## Achievements

- Held senior leadership responsibilities across product development, operations and finance at Genentech.
- Led Genentech’s finance organisation during a period in which revenue tripled, according to Facebook’s 2009 hiring announcement.
- Helped lead Facebook through its May 2012 IPO.
- Co-founded Lyra Health and served as founding CEO for approximately a decade.
- Selected as a Henry Crown Fellow in 2000.

## Latest updates

- **2026-03** — Companies House records his resignation as a director of Lyra International Holdings Limited on March 9, 2026.
- **2025-01** — Transitioned from founding CEO to board chairman at Lyra Health, effective January 13.
- **2024-12** — Lyra announced Jennifer Schulz as his successor as CEO on December 5.

## Links

- Website: https://www.lyrahealth.com/
- LinkedIn: https://www.linkedin.com/in/david-ebersman-6a480b21
- Twitter/X: https://x.com/ebersman
- Instagram: https://www.instagram.com/david.ebersman/

---

Profile page: https://yespress.io/david-ebersman
Published by YesPress — https://yespress.io
Last updated: 2026-10-23